신세포암종의 분류에서 AMACR과 Claudin-7의 유용성
Diagnostic Utility of AMACR and Claudin-7 for the Classification of Renal Cell Carcinoma
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background : The histologic classification of renal cell carcinoma (RCC) is based on the cytoarchitectural features, yet sometimes this requires correlation with the immunophenotype. Alpha-methylacyl-CoA racemase (AMACR) and claudin-7 have recently been introduced as useful markers that are frequently expressed in papillary RCC (PRCC) and chromophobe RCC (ChRCC), respectively. The aims of this study are to evaluate the expressions of AMACR and claudin-7 in RCCs and to investigate whether they are helpful for making the histological classification of RCCs. Methods : Immunohistochemistry for CD10, RCC marker, cytokeratin (CK)7, CD117, AMACR and claudin-7 was performed for 104 RCCs, and these consisted of 54 clear cell RCCs (CCRCC), 26 PRCCs and 24 ChRCCs. Results : For diagnosing PRCC, the sensitivity and specificity of AMACR were 92.3% and 71.8%, respectively, and using AMACR(+)/CK7(+), the specificity was increased by 23.1% to 94.9%. For diagnosing ChRCC, the sensitivity and specificity of claudin-7 were 91.7% and 78.8%, respectively, and using claudin-7(+)/AMACR(-), the specificity was significantly improved (to 96.3%). For diagnosing CCRCC, CK7(-)/claudin-7(-)/CD117(-) was the most useful immunohistochemical panel (sensitivity, 96.3%; specificity, 98%). Conclusions : AMACR and claudin-7 are helpful markers for the histologic classification of RCCs, and their diagnostic utility is strengthened when they are used as an immunohistochemical panel, AMACR(+)/CK7(+) for PRCC, claudin-7(+)/AMACR(-) for ChRCC and CK7(-)/claudin-7(-)/CD117(-) for CCRCC.
Abstract
Background : The histologic classification of renal cell carcinoma (RCC) is based on the cytoarchitectural features, yet sometimes this requires correlation with the immunophenotype. Alpha-methylacyl-CoA racemase (AMACR) and claudin-7 have recently been introduced as useful markers that are frequently expressed in papillary RCC (PRCC) and chromophobe RCC (ChRCC), respectively. The aims of this study are to evaluate the expressions of AMACR and claudin-7 in RCCs and to investigate whether they are helpful for making the histological classification of RCCs. Methods : Immunohistochemistry for CD10, RCC marker, cytokeratin (CK)7, CD117, AMACR and claudin-7 was performed for 104 RCCs, and these consisted of 54 clear cell RCCs (CCRCC), 26 PRCCs and 24 ChRCCs. Results : For diagnosing PRCC, the sensitivity and specificity of AMACR were 92.3% and 71.8%, respectively, and using AMACR(+)/CK7(+), the specificity was increased by 23.1% to 94.9%. For diagnosing ChRCC, the sensitivity and specificity of claudin-7 were 91.7% and 78.8%, respectively, and using claudin-7(+)/AMACR(-), the specificity was significantly improved (to 96.3%). For diagnosing CCRCC, CK7(-)/claudin-7(-)/CD117(-) was the most useful immunohistochemical panel (sensitivity, 96.3%; specificity, 98%). Conclusions : AMACR and claudin-7 are helpful markers for the histologic classification of RCCs, and their diagnostic utility is strengthened when they are used as an immunohistochemical panel, AMACR(+)/CK7(+) for PRCC, claudin-7(+)/AMACR(-) for ChRCC and CK7(-)/claudin-7(-)/CD117(-) for CCRCC.
참고문헌 (28)
- Lopez-Beltran A, "2004 WHO classification of the renal tumors of the adults", Eur Urol, 49, pp.798~805 (2006)
- Kumar V, "Robbins and Cotran: pathologic basis of disease. 8th ed", pp.964~965 (2010), Saunders-Elsevier
- Letang N, "Prognostic factors in renal cell carcinoma", Bull Cancer, 96, pp.475~484 (2009)
- Gobbo S, "Renal cell carcinomas with papillary architecture and clear cell components:the utility of immunohistochemical and cytogenetical analyses in differential diagnosis", Am J Surg Pathol, 32, pp.1780~1786 (2008)
- Mai KT, "Cytohistopathologic hybrid renal cell carcinoma with papillary and clear cell features", Pathol Res Pract, 202, pp.863~868 (2006)
- Abrahams NA, "Oncocytic renal neoplasms:diagnostic considerations", Clin Lab Med, 25, pp.317~339 (2005)
- Ku_mmerlin I, "Diagnostic problems in the subtyping of renal tumors encountered by five pathologists", Pathol Res Pract, 205, pp.27~34 (2009)
- Zhou M, "The usefulness of immunohistochemical markers in the differential diagnosis of renal neoplasms", Clin Lab Med, 25, pp.247~257 (2005)
- Pan CC, "The diagnostic utility of MOC31,BerEP4,RCC marker and CD10 in the classification of renal cell carcinoma and renal oncocytoma:an immunohistochemical analysis of 328 cases", Histopathology, 45, pp.452~459 (2004)
- Allory Y, "Profiling and classification tree applied to renal epithelial tumours", Histopathology, 52, pp.158~166 (2008)
- Molinie V, "Alpha-methyl CoA racemase expression in renal cell carcinomas", Hum Pathol, 37, pp.698~703 (2006)
- Tretiakova MS, "Expression of alphamethylacyl-CoA racemase in papillary renal cell carcinoma", Am J Surg Pathol, 28, pp.69~76 (2004)
- Osunkoya AO, "Claudin-7 and claudin-8:immunohistochemical markers for the differential diagnosis of chromophobe renal cell carcinoma and renal oncocytoma", Hum Pathol, 40, pp.206~210 (2009)
- Hornsby CD, "Claudin-7 immunohistochemistry in renal tumors:a candidate marker for chromophobe renal cell carcinoma identified by gene expression profiling", Arch Pathol Lab Med, 131, pp.1541~1546 (2007)
- Amery L, "Mitochondrial and peroxisomal targeting of 2-methylacyl-CoA racemase in humans", J Lipid Res, 41, pp.1752~1759 (2000)
- Ferdinandusse S, "Subcellular localization and physiological role of alpha-methylacyl-CoA racemase", J Lipid Res, 41, pp.1890~1896 (2000)
- Schmitz W, "Purification and properties of an alpha-methylacyl-CoA racemase from rat liver", Eur J Biochem, 222, pp.313~323 (1994)
- Luo J, "Alpha-methylacyl-CoA racemase:a new molecular marker for prostate cancer", Cancer Res, 62, pp.2220~2226 (2002)
- Zhou M, "Alpha-Methylacyl-CoA racemase:a novel tumor marker over-expressed in several human cancers and their precursor lesions", Am J Surg Pathol, 26, pp.926~931 (2002)
- Jiang Z, "Expression of alpha-methylacyl-CoA racemase(P504s)in various malignant neoplasms and normal tissues:astudy of 761 cases", Hum Pathol, 34, pp.792~796 (2003)
- Tsukita S, "Multifunctional strands in tight junctions", Nat Rev Mol Cell Biol, 2, pp.285~293 (2001)
- Huo Q, "Claudin-1 protein is a major factor involved in the tumorigenesis of colorectal cancer", Anticancer Res, 29, pp.851~857 (2009)
- Ohtani S, "Expression of tight-junctionassociated proteins in human gastric cancer:downregulation of claudin-4 correlates with tumor aggressiveness and survival", Gastric Cancer, 12, pp.43~51 (2009)
- Comper F, "Expression pattern of claudins 5 and 7 distinguishes solid-pseudopapillary from pancreatoblastoma,acinar cell and endocrine tumors of the pancreas", Am J Surg Pathol, 33, pp.768~774 (2009)
- Yoo Duk Choi, "Claudin-7 is Highly Expressed in Chromophobe Renal Cell Carcinoma and Renal Oncocytoma", Journal of Korean Medical Science, 22(2), pp.305~310 (2007), 대한의학회
- Li L, "Expression of claudin-7 in benign kidney and kidney tumors", Int J Clin Exp Pathol, 1, pp.57~64 (2008)
- Takahashi M, "Molecular subclassification of kidney tumors and the discovery of new diagnostic markers", Oncogene, 22, pp.6810~6818 (2003)
- Schuetz AN, "Molecular classification of renal tumors by gene expression profiling", J Mol Diagn, 7, pp.206~218 (2005)